413 results on '"Schrumpf, E"'
Search Results
2. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
3. Liver transplantation in patients over 60 years of age
4. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. (Liver Disease)
5. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
6. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Δ32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
7. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
8. Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
9. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
10. Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients
11. Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
12. NEW TIME DEPENDENT PROGNOSTIC MODELS FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
13. TIME DEPENDENT NEURAL NETWORK PROGNOSTIC MODEL FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
14. NATURAL HISTORY OF PRIMARY SCLEROSING CHOLANGITIS. A LONGTERM FOLLOW-UP STUDY OF 394 EUROPEAN PRIMARY SCLEROSING CHOLANGITIS PATIENTS
15. International Autoimmune Hepatitis Group* Report: review of criteria for diagnosis of autoimmune hepatitis
16. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
17. Primary sclerosing cholangitis: Benefits & downsides of EC support 36.10
18. C01/162 Interferon α2b treatment in low activity hepatitis C infection
19. Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.
20. Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
21. Primary sclerosing cholangitis: challenges of a new millenium
22. Parenting, Child Culture, and Emotional Relations in Postwar Norway
23. Association of the tumour necrosis factor α -- 308 but not the interleukin 10 -- 627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
24. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
25. Liver transplantation in a 23-year-old tyrosinaemia patient: Effects on the renal tubular dysfunction
26. SAT-372 - Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis
27. SAT-347 - Lipid Antigens in Bile from Patients with Liver Diseases Activate Natural Killer T Cells
28. LB02 - Norursodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis: Results of a Phase II Dose Finding Study
29. PS092 - Proteomic Analysis of Liver Fibrotic Septa and Periportal Spaces in Primary Sclerosing Cholangitis, Primary Biliary Cholangitis and Alcoholic Liver Disease
30. P1190 : The role of NKT cells in a mouse model (NOD.C3C4) with spontaneous bile duct inflammation
31. P478 Increased activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis
32. Gallbladder polyps in primary sclerosing cholangitis: not so benign.
33. The 32-base pair deletion of the chemokine receptor 5 gene ( CCR5-Δ 32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
34. Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation.
35. The HLA-DR3,DQ2 Heterozygous Genotype is Associated with an Accelerated Progression of Primary Sclerosing Cholangitis.
36. 165 Array-based approach for early tumour detection in the biliary tract
37. Severe Liver Failure in Exertional Heat Stroke.
38. Liver Transplantations in the Nordic Countries, 1982-1998: Changes of Indications and Improving Results.
39. Acute Effects of Intravenous Cimetidine upon Gastric Secretion in Patients with Impaired Renal Function.
40. Interferon-α2b Therapy in Low-Activity Hepatitis C: A Pilot Study.
41. Hepatic Retention of Copper and Selenium in Primary Sclerosing Cholangitis.
42. Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices.
43. Interferon-α2b, with or without Prior Hepatic Artery Embolization: Clinical Response and Survival in Mid-Gut Carcinoid Patients: The Norwegian Carcinoid Study.
44. Etiology and Pathogenesis in Primary Sclerosing Cholangitis.
45. Effects of Omeprazole and Eradication of Helicobacter pylori on Gastric and Duodenal Mucosal Enzyme Activities and DNA in Duodenal Ulcer Patients.
46. Hepatobiliary Disease in Ulcerative Colitis: An Analysis of 18 Patients with Hepatobiliary Lesions Classified as Small-Duct Primary Sclerosing Cholangitis.
47. Liver Disease in Anti-Hepatitis C Virus-Positive Norwegian Blood Donors.
48. Side Effects and Complications after Hepatic Artery Embolization in the Carcinoid Syndrome.
49. Effect of Misoprostol and Antacids on Gastric and Duodenal Mucosal Enzyme Activities in Duodenal Ulcer Patients.
50. Heterozygous MZ Alpha-1-Antitrypsin Deficiency in Adults with Chronic Liver Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.